Stem cell antigen-1 (Sca-1/Ly6A/E) is a cell surface glycoprotein that is often used as a biomarker for stem cells and cell stemness. However, it is not clear what factors can directly induce the expression of Sca-1/Ly6A/E in T lymphocytes in vivo, and if induction of Sca-1 is associated with T cell stemness. In this study, we show that interleukin-27 (IL-27), a member of the IL-12 family of cytokines, directly induces Sca-1 expression in T cells in vivo. We found that mice-deficient for IL-27 (either P28 or EBI3) or its signalling (IL-27Ra) had profound reduction of Sca-1 expression in naive (CD62L + CD44 À ), memory (CD62L + CD44 + ) and effector (CD62L À CD44 + ) T cells. In contrast, in vivo delivery of IL-27 using adeno-associated viral vectors strongly induced the expression of Sca-1 in naive and memory/effector T-cell populations in an IL-27 receptor-or signal transducer and activator of transcription 1-dependent manner. Interestingly, IL-27-induced Sca-1 + T cells do not express or up-regulate classic stem cell-associated genes such as Nanog, Oct4, Sox2 and Ctnnb1. However, IL-27-induced Sca-1 + T cells had increased expression of effector/ memory-associated transcription factor T-bet, Eomes and Blimp1. Hence, IL-27 signalling directly induces the expression of Sca-1/Ly6A/E expression in T cells. Direct expansion of Sca-1 + CD62L + CD44 À T memory stem cells may explain why IL-27 enhances T-cell memory.
Summary
Stem cell antigen-1 (Sca-1/Ly6A/E) is a cell surface glycoprotein that is often used as a biomarker for stem cells and cell stemness. However, it is not clear what factors can directly induce the expression of Sca-1/Ly6A/E in T lymphocytes in vivo, and if induction of Sca-1 is associated with T cell stemness. In this study, we show that interleukin-27 (IL-27), a member of the IL-12 family of cytokines, directly induces Sca-1 expression in T cells in vivo. We found that mice-deficient for IL-27 (either P28 or EBI3) or its signalling (IL-27Ra) had profound reduction of Sca-1 expression in naive (CD62L + CD44 À ), memory (CD62L + CD44 + ) and effector (CD62L À CD44 + ) T cells. In contrast, in vivo delivery of IL-27 using adeno-associated viral vectors strongly induced the expression of Sca-1 in naive and memory/effector T-cell populations in an IL-27 receptor-or signal transducer and activator of transcription 1-dependent manner. Interestingly, IL-27-induced Sca-1 + T cells do not express or up-regulate classic stem cell-associated genes such as Nanog, Oct4, Sox2 and Ctnnb1. However, IL-27-induced Sca-1 + T cells had increased expression of effector/
Introduction
Interleukin-27 (IL-27) is a member of the IL-12 cytokine family that consists of two subunits, i.e. Epstein-Barr virusinduced gene 3 (EBI3) and P28 (also known as IL-30). 1 IL-27 is produced by activated antigen-presenting cells such as dendritic cells and macrophages, [2] [3] [4] and signals through a heterodimeric receptor (IL-27R) consisting of the WSX-1 and the gp130 subunits in a variety of cell types including T cells. 5 IL-27 activates both the signal transducer and activator of transcription 1 (Stat1) and Stat3 signalling cascade, 6, 7 with the activation of Stat1 being dominant. [8] [9] [10] Hence, IL-27 has potent activity in regulating T helper types 1, 2 and 17, and FoxP3 + regulatory T cell responses. [11] [12] [13] IL-27 is also 
I M M U N O L O G Y O R I G I N A L A R T I C L E
known to induce T-cell expression of IL-10 [14] [15] [16] and programmed death ligand 1 (PD-L1), 17 two inhibitory pathways that are associated with T-cell tolerance.
In addition to the well-appreciated anti-inflammatory effects of IL-27, we and others have shown that IL-27 can also enhance T-cell survival [18] [19] [20] and promote T-cell memory. 18, 21, 22 Our in vitro analysis of IL-27-stimulated cytotoxic T lymphocytes revealed that IL-27 induces T-cell expression of stemness-associated molecule Sca-1/Ly6A. 18 Sca-1 is a cell surface glycoprotein that is expressed in all adult mouse haematopoietic stem cells 23 and also in activated T cells. 24 Haematopoietic stems cells deficient for Sca-1 are defective 25 and T lymphocytes deficient for Sca-1 have altered proliferative responses. 24 Recently, we also showed that Sca-1 could be induced in T cells by in vivo delivery of IL-27 using adeno-associated viral (AAV) vectors. 26 However, it remains unclear if IL-27 directly induces Sca-1 expression in T cells, and if its induction is associated with T-cell stemness.
Previous studies have revealed a group of CD62L + CD44 À Sca-1 + T cells that are termed as T memory stem cells (T SCM ). T SCM cells are an early-stage T memory subset that has robust proliferative potential, long-term survival capacity and the ability to mediate superior tumour regression upon adoptive transfer into tumour-bearing mice. 27, 28 T SCM cells can be generated by programming naive T cells in the presence of glycogen synthase-3b inhibitors 27, 28 or cytokines such as IL-15 29 and IL-21. 30 It would therefore be interesting to determine if IL-27 can induce the expansion of T SCM cells.
In this study, we have examined whether IL-27 signalling directly induces Sca-1 expression in T cells in vivo and if induction of Sca-1 is associated with T-cell stemness. We found that mice deficient for IL-27 (either P28 or EBI3) or its receptor (IL-27Ra) had profound reduction of Sca-1 expression in both naive and memory T-cell populations. In contrast, in vivo delivery of IL-27 by AAV significantly induced the expression of Sca-1 in naive and memory Tcell populations in IL-27 receptor-and Stat1-dependent manners. Interestingly, IL-27-induced Sca-1 expression is not associated with T-cell stemness, as IL-27-stimulated T cells failed to up-regulate traditionally stemness-associated genes such as Nanog, Oct4, Sox2 and Ctnnb1. In vivo delivery of IL-27 by AAV induced an effector/memory phenotype in T cells characterized by the expression of T-bet, Eomes and Blimp1. Hence, IL-27 signalling directly induces the expression of Sca-1/Ly6A expression in T cells. Direct expansion of Sca-1 + CD62L + CD44 À T SCM cells may explain why IL-27 enhances T-cell memory.
Materials and methods
Mice C57BL/6 mice and IL-27Ra À/À mice were purchased from the Jackson Laboratory (Bar Harbor, ME). EBI3-deficient mice in the C57BL/6 31 and BALB/c background 22 have been described. C57BL/6 mice with a targeted mutation of the P28 gene (IL-27P28 À/À ) 13 were obtained from Dr Daniel J. Cua via a material transfer agreement. Stat1-deficient BALB/c mice 32 have been described previously. All mice were maintained in OSU laboratory animal facilities that were fully accredited by Institutional Animal Care and Use Committee.
Antibodies and flow cytometry
Fluorescein isothiocyanate-, phycoerythrin-, allophycocyanin-or Peridinin chlorophyll protein-labelled antibodies to CD4, CD8a, CD44, CD62L, PD-L1, Sca-1 and isotype control antibodies were purchased from BD Biosciences (San Diego, CA). For staining of cell surface markers, cells (single-cell suspensions of spleen) were stained with various antibodies in staining buffer (PBS with 1% fetal calf serum) on ice for 30 min, after washing with staining buffer, cells were fixed in 1% paraformaldehyde in PBS and were analysed on a FACSCalibur flow cytometer. Data were analysed using FLOWJO software (Tree Star, Inc., Ashland, OR).
Production of adeno-associated viral vectors and mice treatment
We used rAAV vector to express IL-27 and IL-30 in vivo. The IL-30 expression plasmids 33 were obtained from Dr Shulin Li (MD Anderson Cancer Center). Briefly, IL-27 or IL-30 cDNA was inserted into an AAV carrier vector under the control of the cytomegalovirus-chicken b-actin hybrid (CAG) promoter. 34, 35 The IL-27 or IL-30 carrier AAV vector was compacted with a helper vector in 293K cells into the AAV serotype 8 (AAV8). AAV8 is known to be particularly suitable for expression in muscle cells. 36, 37 Intramuscular injection of 2 9 10 11 DNAse resistant particle (DRP)/mouse of AAV-IL-27 or AAV-IL-30 achieved high concentrations of IL-27 or IL-30 production in the peripheral blood of mice. Hence, we evaluated the in vivo effects of AAV-IL-27 and AAV-IL-30 on T-cell activation in the context of a concanavalin A-induced liver injury model.
ELISA
Blood was drawn from mice treated with AAV-IL-27, AAV-IL-30 and AAV-ctrl vectors at 2 weeks after viral injection. Serum was investigated for the presence of IL-27 and IL-30 using ELISA kits purchased from eBioscience (San Diego, CA) for IL-27 and R&D Systems, Inc. (Minneapolis, MN) for IL-30.
Real-time PCR
Quantitative real-time PCR was performed using an ABI 7900-HT sequence system (PE Applied Biosystems, Foster City, CA) with the QuantiTect SYBR Green PCR kit (Qiagen, Hilden, Germany) in accordance with the manufacturer's instructions. PCR was performed using previously determined conditions. 38 The following primers were used for amplifying specific genes: Actin: 5 0 -GAG ACCTTCAACACCCCAGC-3 0 (forward) and 5 . Sca-1 expression in CD4 + and CD8 + T cells and their subsets were quantified (c). Three to five mice were used in each group for this experiment. Data are expressed as means of individual determinations AE SE and represent three experiments using both male and female mice. Statistical analysis was performed using the unpaired Student's t-test. *P < 0Á05; **P < 0Á01; ***P < 0Á001. N.S., not significant. 
Statistics
Data are expressed as means of individual determinations AE SE. Statistical analysis was performed using the unpaired Student's t-test.
Results
Reduced Sca-1/Ly6A expression in T cells in IL-27 and IL-27 receptor-deficient mice Previous studies 18, 21, 22 have revealed that IL-27 contributes to T-cell memory, and expression of Sca-1/Ly6A, a cell surface glycoprotein, is considered to be a biomarker for T SCM . 28 We therefore examined if the lack of IL-27 or IL-27 receptor signalling affected T-cell expression of Sca-1 in naive and memory T-cell populations. In the peripheral lymphoid organs of naive mice, T cells can be sub-divided into three populations based on their expression of CD62L and CD44, i.e. CD62L + CD44 À (naive), CD62L + CD44 + (central memory) and CD62L À CD44 + (effector memory) T cells. As shown in Fig. 1(a) , CD4 + and CD8 + T cells from IL-27P28-deficient and wild-type B6 mice were subdivided into three populations based on their expression of CD62L and CD44. We found that CD4 + and CD8 + T cells and their subpopulations from IL-27P28 À/À mice had significantly reduced expression of Sca-1, and the reduction of Sca-1 expression was particularly significant among memory T-cell populations in both CD4 + and CD8 + T cells (Fig. 1b,c) expressed as means of individual determinations AE SE and represent three experiments using both male and female mice. Statistical analysis was performed using the unpaired Student's t-test. *P < 0Á05; ***P < 0Á001. N.S., not significant. (Fig. 2b,c) . Finally, the T-cell subpopulations in IL-27Ra À/À mice (Fig. 3a) were also analysed in a similar manner. Significant reduction of Sca-1/Ly6A expression was observed in all subpopulations of CD4 + and CD8 + T cells in IL-27Ra À/À mice (Fig. 3b,c) . Hence, IL-27-IL-27R signalling appears to be required for the expression of Sca-1/Ly6A in both naive and memory/effector T cells under steady state.
IL-27 directly induce Sca-1/Ly6A in T cells in an IL-27R-or Stat1-dependent manner
We previously showed that cultured T cells stimulated with IL-27 up-regulated Sca-1/Ly6A. 18 We also observed that T cells in AAV-IL-27-treated mice had increased expression of Sca-1/Ly6A. 26 To determine if IL-27 directly induces Sca-1 expression in T cells in vivo, we generated AAV-IL-27, AAV-IL-30 (IL-27P28) or AAVCtrl viral vectors and injected the vectors intramuscularly into wild-type mice. As shown in Fig. 4(a) , 2 weeks after the injection of viral vectors, significant levels of IL-27 or IL-30 were detected only in the serum from mice receiving respective AAV vectors. Multi-coloured flow cytometry analysis was used to determine the expression of Sca-1. As shown in Fig. 4(b) and summarized in Fig. 4(c,d) , T cells from AAV-IL-27, but not AAV-IL-30 or AAV-Ctrl viral vector-treated mice had significantly up-regulated expression of Sca-1, essentially in all subpopulations. These results confirm that IL-27, but not its subunit P28 (IL-30), induces Sca-1 expression in all T-cell subpopulations in vivo. Moreover, we found that AAV-IL-27-induced Sca-1 expression was IL-27R and Stat1-dependent, as AAV-IL-27-induced Sca-1 expression was only detected in T cells from wild-type, but not IL-27Ra (Fig. 5a ) and Stat1-deficient mice (Fig. 5b) . 
T cells
To understand the phenotypes of AAV-IL-27-induced Sca-1 + T cells, we sorted CD4 + and CD8 + T cells from AAV-IL-27 and AAV-ctrl virus-treated mice by FACS, and used quantitative PCR to measure T-cell differentiations and stemness-associated transcription factors. As shown in Fig. 6 , AAV-IL-27 treatment significantly up-regulated the expression of T-bet, Eomes and Blimp1, transcription factors typically expressed by effector memory T cells. 39 We failed to detect the expression of stem cell-associated transcription factors 40 such as Nanog, Oct4 and Sox2, in T cells from either AAV-IL-27 or AAV-ctrl virus-treated mice. Induction of Ctnnb1 (b-catenin) has been shown to be associated with T-cell stemness. 28 However, we found that Ctnnb1 was slightly reduced in T cells from AAV-IL-27-treated mice. Finally, Klf4 up-regulation was found in CD4 + , but not CD8 + , T cells from AAV-IL-27-treated mice. Hence, IL-27-induced Sca-1 + T cells express transcription factors of effector memory T cells but do not show many features of typical stem cells.
Discussion
In this study, we have found that IL-27 directly induces Sca-1 expression in naive and memory T cells in vivo. In IL-27 and IL-27 receptor-deficient mice, Sca-1 expression is greatly reduced in all three populations of T cells, i.e. CD62L + CD44 À naive, CD62L + CD44 + central memory and CD62L
À CD44 + effector memory T cells. In contrast, in mice treated with AAV-IL-27, Sca-1 expression is greatly increased in naive, central memory and effector memory T cells, and AAV-IL-27-induced Sca-1 expression is IL-27R-and Stat1-dependent. Hence, our results suggest that IL-27 signalling directly induces the expression of Sca-1/Ly6A/E in T cells in vivo.
Demoulin et al. 41 showed that IL-6 and IL-9 induced the expression of Sca-1 in T lymphoma cells and mature T lymphocytes in vitro. They found that both IL-6 and IL-9 mediated the transcriptional activation of Sca-1 through a GAS element in the Sca-1 promotor, which was able to bind Stat1 and Stat3. In this study, we found that IL-27 signalling induced Sca-1 expression in vivo exclusively through Stat1 (Fig. 5b) . Hence, it is likely that IL-27-induced activation of Stat1 directly binds to GAS element in the Sca-1 promoter, leading to the expression of Sca-1 in T cells.
Sca-1/Ly6A/E is a cell surface glycoprotein that is expressed in all adult mouse haematopoietic stem cells 23 and has been shown to be necessary for haematopoietic was examined by flow cytometry and MFI of Sca-1 was quantified. Three to five mice were used in each group for the experiments. Data are expressed as means of individual determinations AE SE and represent two independent experiments using both male and female mice. Statistical analysis was performed using the unpaired Student's t-test. ***P < 1 9 10 À3 .
ª 2017 John Wiley & Sons Ltd, Immunology, 152, 638-647 stem cell self-renewal and the development of committed progenitor cells. 25 Sca-1 was also shown to play a role in c-kit expression in haematopoietic stem cells 42 and in haematopoietic commitment to granulocyte development. 43 However, our current results suggest that IL-27-induced Sca-1 expression does not appear to be associated with stemness of mature T cells, as the classic transcription factors associated with cell stemness, including Nanog, Oct4 and Sox2, were undetectable in Sca-1 + T cells from AAV-IL-27-treated mice (Fig. 6 ), whereas Klf4 expression was only found to be elevated in CD4 + but not CD8 + T cells. Induction of Ctnnb1 (b-catenin) has also been shown to be associated with T-cell stemness. 28 However, we found that Ctnnb1 was slightly reduced in T cells from AAV-IL-27-treated mice (Fig. 6) . Hence, IL-27-induced Sca-1 + T cells do not show many features of conventional stem cells. These results suggest that Sca-1 expression in haematopoietic stem cells and mature T lymphocytes play different roles.
Although IL-27-induced Sca-1 + T cells do not express many stem cell-associated genes, they have elevated expression of memory T-cell-associated molecules such as Eomes, which have been shown to promote T-cell memory. 44, 45 In this study, we have found that IL-27 induces Sca-1 expression in all three populations of T cells, i. 27, 28 and cytokines such as IL-15 29 and IL-21. 30 Our results provide the first evidence that IL-27 signalling induces the expansion of CD62L + CD44 À Sca-1 + T SCM cells in vivo. These findings, taken together, explain why IL-27 promotes T-cell memory. 18, 21, 22 However, these results do not suggest that Sca-1 itself is important for T-cell memory, as Sca-1-deficient mice have normal T-cell memory responses. 46 Taken together, we have found that IL-27 signalling can directly induce Sca-1/Ly6A/E expression in naive and memory populations of T cells. However, IL-27-induced Sca-1 + T cells do not express the classic transcription factors for stemness. IL-27 induces the expansion of a memory pool of T cells including T SCM cells. Given that IL-27 may potentially be used as a therapeutic for cancer 47 and autoimmune diseases, 48 identification of Sca-1/Ly6A/E as an IL-27-responsive biomarker in T cells in vivo may potentially be useful for determining therapeutic response in pre-clinical settings. from China Natural Science Foundation (81572805). The Samples were pooled from three mice in each group. Data are expressed as means of individual determinations AE SE of three replicates, and represent two independent experiments. Statistical analysis was performed using the unpaired Student's t-test. *P < 0Á05; **P < 0Á01. nd, not detectable. 
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